The "Ensuring Reproductive Freedom by Shielding Our Providers Act" aims to protect the anonymity of healthcare providers by allowing them to request that their health care practice's name be used on prescription labels for mifepristone or misoprostol, rather than their individual names. This act defines key terms such as "dispenser," "pharmacy," "physician," "prescriber," and "provider," establishing a clear framework for who is covered under this legislation.

Under the provisions of the bill, if a provider requests that their health care practice's name be used on a prescription label, the dispenser or pharmacy is required to comply with this request. This measure is intended to enhance the privacy of providers involved in the prescription of these medications, thereby supporting reproductive freedom. The act is set to take effect 30 days after its passage.